EmVision Medical Devices Limited (ASX:EMV)

EMV aim to change the Stroke Care paradigm and in doing so positively impact the lives of millions.

About Us

EMvision Medical Devices Limited is seeking to commercialise the EMvision Technology (“EMVT”) – innovative medical imaging / diagnostic technology originally developed by the University of Queensland.

Company Overview

The EMVT is a system for mapping dielectric parameters of tissue and processing data from low power microwave signals to rapidly reconstruct 3D imaging necessary for key medical diagnostic and monitoring purposes. Microwave imaging provides a different spatial resolution from that of a CT or MRI, with a high sensitivity to physiological factors of clinical interest, such as temperature, blood flow and water content. The potential advantages of microwave imaging arise from the high contrast of dielectric properties between healthy and unhealthy tissue.
Existing medical imaging techniques can be cumbersome, expensive and/or use high energy radiation, reducing their utility in several applications, including applications where rapid response times are desirable or where ongoing point of care monitoring is desirable to assess treatment efficacy.
The EMVT uses low energy microwave signals for imaging diagnostics, which is then processed using novel EMVT algorithms to enable 3D images to be generated, assisting diagnosis and monitoring providing rapid and portable utility that traditional EM imaging such as CT or MRI cannot offer. The use of low energy microwave signals allows the EMVT technology to be portable and potentially deployed by first response paramedics to assess patient conditions and facilitate ultra early and more effective treatment. The initial focus of the Company is the development of the EMVT for rapid and effective diagnosis and monitoring of stroke. Rapid diagnosis is necessary to enable prompt and effective treatment to minimise any loss of brain function following a stroke. Early treatment after a stroke is widely recognised as a key factor in minimising the effects of a stroke.

Board & Management

John Keep

John Keep

Chairman

John has extensive experience in managing both start-ups and enterprise level businesses. As CEO of Queensland Diagnostic Imaging, John grew the business to become the state’s leading private imaging group and led the successful trade sale of the group to Mayne Pharma for $109 million. John leads the development and execution of EMVision’s strategy and manages its research and engineering partnerships.

Dr. Ron Weinberger

Dr. Ron Weinberger

CEO and Managing Director

Dr. Ron Weinberger is the Former Exec Director and CEO of Nanosonics' (ASX:NAN), an $2bn market cap healthcare company. He has over 20-years’ experience developing and commercialising medical devices. During his time at Nanosonics, Dr. Weinberger co-developed the company’s platform technology, launched their breakthrough product ‘Trophon’ globally and created a North American sales team to work alongside GE healthcare. He was instrumental in transforming Nanosonics from a research and development company to one of Australia’s leading medical device commercialisation success stories.

Scott Kirkland

Scott Kirkland

Executive Director

Scott is the co-founder of EMVision Medical Devices Ltd. Scott has held several senior sales positions, including Head of Client Sales at Quantcast, a US-based technology company, prior to founding Kirkland Capital, targeting emerging technologies. Scott oversees EMVision's corporate affairs, commercial strategy and business development efforts. Scott is also charged with optimising the company’s capital requirements, including further non-dilutive financing and grants. Scott is a member of the Australian Institute of Company Directors.

Tony Keane

Tony Keane

Non-Executive Director

Tony is an experienced Business and Finance executive with an extensive background in banking & business management and is actively involved in the business community through Non-Executive Director roles and finance advisory consultancies. He is a Director of National Storage Holdings Ltd (ASX:NSR) and Queensland Symphony Orchestra Pty Ltd, and Chairman of their Audit and Risk Committees. He is also an Advisory Board member for several private companies. Tony previously held numerous roles with a major trading bank principally in business, corporate and institutional banking. He has a Bachelor of Science (Mathematics) degree and a Graduate Diploma in Corporate Finance, is a Fellow of the Financial Services Institute of Australasia, and a Graduate of the Australian Institute of Company Directors.

Geoff Pocock

Geoff Pocock

Non-Executive Director

Geoff has over 20 years’ experience in commercialisation, corporate finance and strategy, and has specialised in the commercialisation and funding of early-stage research projects from universities and taking spin-out companies to successful ASX listings. Geoff is currently Non-Executive Chairman of Argenica Therapeutics Ltd (ASX:AGN), recently spun out from the Perron institute of Neurological and Translational Research, and he is the founder and former Managing Director of Hazer Group Limited (ASX:HZR), which arose from The University of Western Australia. Geoff has tertiary qualifications in Chemistry, Law and Applied Finance and is a Member of the Australian Institute of Company Directors.

Dr. Philip Dubois

Dr. Philip Dubois

Non-Executive Director

Dr. Dubois is an imaging executive and neuroradiologist. Dr. Dubois is Non-executive Director of Sonic Healthcare (ASX:SHL), former CEO of their imaging division and served as Executive Director from 2001 to 2020. He is also the founder and former CEO and Chairman of Queensland X-Ray. Dr Dubois is currently an Associate Professor of Radiology at the University of Queensland Medical School. He has served on numerous government and radiology group bodies, including the councils of the Royal Australian and New Zealand College of Radiologists and the Australian Medical Association, and as Vice-President of the Australian Diagnostic Imaging Association.

EmVision Medical Devices Limited

Follow EmVision Medical Devices Limited

By submitting your information below you can keep up to date with their relevant news and announcements.

Fields marked with * are required.

Name(Required)

Cancel